XML 126 R36.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Intangible Assets, Net (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of Indefinite-Lived Intangible Assets, Net | At December 31, 2023, intangible assets, net consisted of the following (in thousands):
| Useful Life (Years) |  | Gross January 1, 2023 |  | Additions |  | Impairment/ Disposal |  | Gross December 31, 2023 |  | Accumulated Amortization |  | Net December 31, 2023
Indefinite lived assets: |  |  |  |  |  |  |  |  |  |  |  |  |
Trademarks | N/A |  | $ | 2,150 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,150 |  |  | $ | — |  |  | $ | 2,150 |
Amortized intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |
Network relationships | 11-21 |  | 150,679 |  |  | — |  |  | — |  |  | 150,679 |  |  | (104,859) |  |  | 45,820 |
Management contracts | 15 |  | 22,832 |  |  | — |  |  | — |  |  | 22,832 |  |  | (16,662) |  |  | 6,170 |
Member relationships | 10-14 |  | 16,633 |  |  | 7,444 |  |  | — |  |  | 24,077 |  |  | (7,345) |  |  | 16,732 |
Patient management platform | 5 |  | 2,060 |  |  | — |  |  | — |  |  | 2,060 |  |  | (2,060) |  |  | — |
Tradename/trademarks | 20 |  | 1,011 |  |  | — |  |  | — |  |  | 1,011 |  |  | (308) |  |  | 703 |
Developed technology | 6 |  | 107 |  |  | — |  |  | — |  |  | 107 |  |  | (34) |  |  | 73 |
|  |  | $ | 195,472 |  |  | $ | 7,444 |  |  | $ | — |  |  | $ | 202,916 |  |  | $ | (131,268) |  |  | $ | 71,648 |
At December 31, 2022, intangible assets, net consisted of the following (in thousands):
| Useful Life (Years) |  | Gross January 1, 2022 |  | Additions |  | Impairment/ Disposal |  | Gross December 31, 2022 |  | Accumulated Amortization |  | Net December 31, 2022
Indefinite Lived Assets: |  |  |  |  |  |  |  |  |  |  |  |  |
Trademarks | N/A |  | $ | 2,150 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,150 |  |  | $ | — |  |  | $ | 2,150 |
Amortized intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |
Network relationships | 11-21 |  | 150,679 |  |  | — |  |  | — |  |  | 150,679 |  |  | (95,451) |  |  | 55,228 |
Management contracts | 15 |  | 22,832 |  |  | — |  |  | — |  |  | 22,832 |  |  | (15,208) |  |  | 7,624 |
Member relationships | 12 |  | 8,997 |  |  | 7,636 |  |  | — |  |  | 16,633 |  |  | (5,619) |  |  | 11,014 |
Patient management platform | 5 |  | 2,060 |  |  | — |  |  | — |  |  | 2,060 |  |  | (2,060) |  |  | — |
Tradename/trademarks | 20 |  | 1,011 |  |  | — |  |  | — |  |  | 1,011 |  |  | (257) |  |  | 754 |
Developed technology | 6 |  | — |  |  | 107 |  |  | — |  |  | 107 |  |  | (16) |  |  | 91 |
|  |  | $ | 187,729 |  |  | $ | 7,743 |  |  | $ | — |  |  | $ | 195,472 |  |  | $ | (118,611) |  |  | $ | 76,861 |
Schedule of Finite-Lived Intangible Assets, Net | At December 31, 2023, intangible assets, net consisted of the following (in thousands):
| Useful Life (Years) |  | Gross January 1, 2023 |  | Additions |  | Impairment/ Disposal |  | Gross December 31, 2023 |  | Accumulated Amortization |  | Net December 31, 2023
Indefinite lived assets: |  |  |  |  |  |  |  |  |  |  |  |  |
Trademarks | N/A |  | $ | 2,150 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,150 |  |  | $ | — |  |  | $ | 2,150 |
Amortized intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |
Network relationships | 11-21 |  | 150,679 |  |  | — |  |  | — |  |  | 150,679 |  |  | (104,859) |  |  | 45,820 |
Management contracts | 15 |  | 22,832 |  |  | — |  |  | — |  |  | 22,832 |  |  | (16,662) |  |  | 6,170 |
Member relationships | 10-14 |  | 16,633 |  |  | 7,444 |  |  | — |  |  | 24,077 |  |  | (7,345) |  |  | 16,732 |
Patient management platform | 5 |  | 2,060 |  |  | — |  |  | — |  |  | 2,060 |  |  | (2,060) |  |  | — |
Tradename/trademarks | 20 |  | 1,011 |  |  | — |  |  | — |  |  | 1,011 |  |  | (308) |  |  | 703 |
Developed technology | 6 |  | 107 |  |  | — |  |  | — |  |  | 107 |  |  | (34) |  |  | 73 |
|  |  | $ | 195,472 |  |  | $ | 7,444 |  |  | $ | — |  |  | $ | 202,916 |  |  | $ | (131,268) |  |  | $ | 71,648 |
At December 31, 2022, intangible assets, net consisted of the following (in thousands):
| Useful Life (Years) |  | Gross January 1, 2022 |  | Additions |  | Impairment/ Disposal |  | Gross December 31, 2022 |  | Accumulated Amortization |  | Net December 31, 2022
Indefinite Lived Assets: |  |  |  |  |  |  |  |  |  |  |  |  |
Trademarks | N/A |  | $ | 2,150 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,150 |  |  | $ | — |  |  | $ | 2,150 |
Amortized intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |
Network relationships | 11-21 |  | 150,679 |  |  | — |  |  | — |  |  | 150,679 |  |  | (95,451) |  |  | 55,228 |
Management contracts | 15 |  | 22,832 |  |  | — |  |  | — |  |  | 22,832 |  |  | (15,208) |  |  | 7,624 |
Member relationships | 12 |  | 8,997 |  |  | 7,636 |  |  | — |  |  | 16,633 |  |  | (5,619) |  |  | 11,014 |
Patient management platform | 5 |  | 2,060 |  |  | — |  |  | — |  |  | 2,060 |  |  | (2,060) |  |  | — |
Tradename/trademarks | 20 |  | 1,011 |  |  | — |  |  | — |  |  | 1,011 |  |  | (257) |  |  | 754 |
Developed technology | 6 |  | — |  |  | 107 |  |  | — |  |  | 107 |  |  | (16) |  |  | 91 |
|  |  | $ | 187,729 |  |  | $ | 7,743 |  |  | $ | — |  |  | $ | 195,472 |  |  | $ | (118,611) |  |  | $ | 76,861 |
Schedule of Future Amortization Expense | Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):
| Amount
2024 | $ | 12,818 |
2025 | 11,661 |
2026 | 10,232 |
2027 | 8,794 |
2028 | 7,603 |
Thereafter | 18,390 |
| $ | 69,498 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b),(d) -SubTopic 30 -Topic 350 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3 + Details
Name: | us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration